This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Cambridge. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Viktoria Stelzhammer: Innovator in Antidepressant Therapy
Introduction
Viktoria Stelzhammer is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of mental health through her innovative research. Her work focuses on improving the effectiveness of antidepressant treatments.
Latest Patents
Viktoria holds a patent for a "Marker for response to antidepressant therapy." This invention relates to the use of ApoA4 as a biomarker for predicting whether a patient will respond to antidepressant treatment. The patent also includes methods and kits designed to utilize this biomarker for predicting patient responses.
Career Highlights
Viktoria is affiliated with the University of Cambridge, where she conducts her research. Her work has garnered attention for its potential to enhance treatment outcomes for patients suffering from depression.
Collaborations
Viktoria collaborates with esteemed colleagues, including Sabine Bahn and Man Kuan Chan. Their combined expertise contributes to the advancement of research in the field of mental health.
Conclusion
Viktoria Stelzhammer's innovative work in identifying biomarkers for antidepressant therapy represents a significant advancement in mental health treatment. Her contributions are paving the way for more effective patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile